A first-in-human study to evaluate the safety, tolerability and pharmacokinetics of RP3128, an oral calcium release-activated calcium (CRAC) channel modulator in healthy volunteers.
- DOI
- 10.1111/jcpt.13322
- Published
- 2021 Jun
- Container
- Journal of clinical pharmacy and therapeutics
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/jcpt.13322,
title = {A first-in-human study to evaluate the safety, tolerability and pharmacokinetics of RP3128, an oral calcium release-activated calcium (CRAC) channel modulator in healthy volunteers.},
author = {Barde PJ and Viswanadha S and Veeraraghavan S and Vakkalanka SV and Nair A},
year = {2021},
journal = {Journal of clinical pharmacy and therapeutics},
doi = {10.1111/jcpt.13322},
url = {https://doi.org/10.1111/jcpt.13322}
}RIS
TY - JOUR TI - A first-in-human study to evaluate the safety, tolerability and pharmacokinetics of RP3128, an oral calcium release-activated calcium (CRAC) channel modulator in healthy volunteers. AU - Barde PJ AU - Viswanadha S AU - Veeraraghavan S AU - Vakkalanka SV AU - Nair A PY - 2021 JO - Journal of clinical pharmacy and therapeutics DO - 10.1111/jcpt.13322 UR - https://doi.org/10.1111/jcpt.13322 ER -
APA
PJ, B., S, V., S, V., SV, V., & A, N. (2021). A first-in-human study to evaluate the safety, tolerability and pharmacokinetics of RP3128, an oral calcium release-activated calcium (CRAC) channel modulator in healthy volunteers.. Journal of clinical pharmacy and therapeutics. https://doi.org/10.1111/jcpt.13322
Source records
- pubmed · retrieved 2026-09-26T19:05:32.695Z
- europe-pmc · retrieved 2026-09-26T19:05:32.721Z